Sympatient
Sympatient is a Hamburg-based German healthtech company that builds PsyOS®, a regulated operating system for psychotherapy, integrating patient access, practice operations, AI-supported documentation, and digital therapeutics delivered by licensed clinicians via German statutory and private insurance reimbursement.
- Company typePrivate
- Founded2018
- HeadquartersHamburg, Germany
- Headcount51–100
- GTM typeB2B and B2C
- OfferingServices
What Sympatient does
Sympatient is a Hamburg-based German healthtech company (founded 2017/2018) that develops PsyOS®, a proprietary operating system for modern psychotherapy delivered within Germany's regulated healthcare system. PsyOS® integrates patient access, practice operations, treatment workflows, AI-supported documentation, digital diagnostics, digital therapeutics, and structured longitudinal data into a unified platform. The company delivers care through a network of licensed clinicians (approbierte Behandler:innen) operating under statutory (gesetzliche Krankenversicherung) and private (private Krankenversicherung) reimbursement frameworks, including selective contracts under §140a SGB V. Its product portfolio includes the core PsyOS® platform, the Digital Anxiety Clinic service offering (digital, classical, and hybrid therapy for anxiety disorders), and Invirto, a VR-based digital therapeutic reimbursable under §33a SGB V. AI is applied to clinical documentation automation and to generating structured longitudinal data for outcome improvement, but is not the company's primary differentiator.
The company's revenue model is anchored in regulated reimbursement rather than direct consumer pricing, with income flowing through statutory insurance reimbursement, selective contracts (§140a SGB V), private insurance reimbursement, and Digital Anxiety Clinic service delivery — all characterized as recurring subscription-style relationships with institutional payers. Go-to-market operates through two parallel channels: enterprise-style partnerships with statutory and private health insurers and professional associations, and a partner/recruitment channel bringing licensed clinicians into the Sympatient network to deliver PsyOS®-enabled care. Customer segments span licensed psychotherapists (primary demand-side user), health insurers and professional associations (B2B partners), and patients with anxiety disorders (primary end consumer). The company has raised approximately €9M in venture funding across two rounds (2020 and 2022), both led by Verve Ventures, operates with 51-100 employees, and holds ISO 27001 and GDPR certifications. Single-country operations in Germany limit geographic diversification, but the regulatory depth creates strong domestic barriers to entry.
Sympatient firmographics
Firmographics- Name
- Sympatient
- Legal name
- Sympatient GmbH
- Website
- https://sympatient.com
- Company type
- Private
- Founded year
- 2018
- Operating status
- Operating
- Headcount range
- 51–100 employees
- Short description
- Sympatient is a Hamburg-based German healthtech company that builds PsyOS®, a regulated operating system for psychotherapy, integrating patient access, practice operations, AI-supported documentation, and digital therapeutics delivered by licensed clinicians via German statutory and private insurance reimbursement.
- Ownership category
- akta.pro rank
Sympatient industry classification
Industry- Product category
- Digital Mental Health Services
- NAICS
- Social Assistance (624)
- SIC
- Services-Health Services (8000), Services-Misc Health & Allied Services, Nec (8090)
- akta.pro primary industry
- Serious Mental Illness (SMI) Telepsychiatry & Care Coordination Platforms (HLALAEAH)
- akta.pro secondary industries
- DTx/SaMD Deployment, Integration & Reimbursement Enablement (HLACANAO), DTx/SaMD Regulatory, Quality & Compliance Software (QMS/ISO/FDA) (HLACANAN)
Keywords
Where Sympatient is headquartered
LocationHeadquarters
- HQ city
- Hamburg
- HQ country
- Germany
- HQ region
- Europe
Offices1 record
Markets served
Sympatient business model
Business model- GTM type
- B2B and B2C
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Revenue model
- Statutory Health Insurance Reimbursement: Care delivered by licensed clinicians within regulated statutory reimbursement frameworks (gesetzliche Krankenversicherung). Revenue flows through established reimbursement structures in the German healthcare system.
- Selective Contracts (§140a SGB V): Structured agreements with health insurers through selective contracts that enable innovative care models and reimbursement pathways beyond standard statutory coverage.
- Private Health Insurance Reimbursement: Structured agreements with private health insurers (private Krankenversicherungen) for psychotherapy services delivered through PsyOS® care models.
- Digital Anxiety Clinic Services: Digital, classical, or hybrid therapy options for anxiety disorders offered through the company's Digital Anxiety Clinic, delivered within regulated reimbursement structures.
Go-to-market motion2 records
Distribution channels3 records
Marketing channels7 records
Sympatient product offering
Product offeringCore offering
Sympatient develops PsyOS®, an operating system for modern psychotherapy that connects software, services, and data within Germany's regulated healthcare system. The platform integrates patient access, practice operations, treatment workflows, AI-supported documentation, and digital therapeutics. Through its network of licensed clinicians, the company delivers psychotherapy care via the Digital Anxiety Clinic, offering digital, classical, and hybrid therapy options reimbursed through statutory and private health insurance frameworks including §140a SGB V selective contracts.
Product overview
Sympatient offers PsyOS®, a unified operating system platform for modern psychotherapy that integrates patient access management, practice operations, treatment pathways, AI-supported documentation, digital therapeutics, and structured outcome data. The platform enables care delivery through standardized short-term therapy models, group formats, and blended care approaches. The company's product portfolio includes its core PsyOS® platform, the Digital Anxiety Clinic service offering, and the Invirto digital therapeutic (DTx) product for VR-based anxiety therapy.
Differentiator
Problem solved
Functional benefit
Brands
- PsyOS®: The operating system for modern psychotherapy developed by Sympatient. PsyOS® is a software-enabled care infrastructure that connects software, services and data to make psychotherapeutic care more accessible, practice operations more efficient, and licensed clinicians able to focus more on therapy.
Products and services
- PsyOS® An operating system for modern psychotherapy that connects software, services, and data within regulated healthcare systems, integrating patient access, practice operations, treatment workflows, digital therapeutics, and structured data to make psychotherapy more accessible, scalable, and easier to deliver for licensed clinicians and healthcare partners.
- Digital Anxiety Clinic A digital mental health clinic offering treatment for anxiety disorders through digital, classical, or hybrid therapy formats, delivered by licensed clinicians and reimbursed through statutory and private health insurance frameworks in Germany.
- Invirto A digital therapeutic (DTx) product offering VR-based psychotherapy for anxiety disorders, available as a reimbursable digital health application under §33a SGB V in Germany.
Quantifiable outcome
- Faster treatment initiation through centralized patient operations and intelligent scheduling matching demand with therapist capacity
- +3 more outcomes
Companies that use Sympatient
Customer profileSegments4 records
Ideal customer profiles3 records
Sympatient technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
AI capability2 records
Feature5 records
Sympatient partnerships and signals
Strategic signalScale indicators2 records
Recent moves6 records
Expansion highlights5 records
Sympatient competitors and assessment
Company assessmentBroad incumbents
- Kry/Livi: Kry (now Livi in some markets) is a major European telehealth platform operating across multiple countries including Germany. It is a broad incumbent in virtual care with overlapping mental health capabilities, though its scope extends well beyond psychotherapy into general practice telemedicine.
- Doctolib: Doctolib is a major European healthcare booking and practice management platform with strong presence in Germany and France. While primarily known for appointment scheduling, it has expanded into practice software and teleconsultation, making it a broad incumbent with overlapping customer base (therapists, insurers) but different core focus.
- Zava: Zava is a European digital healthcare provider offering online consultations and treatment across multiple specialties including mental health. It overlaps with Sympatient in regulated online healthcare delivery in Germany and other European markets, though mental health is only one of several service lines.
Direct peers
- Minddoc: Minddoc is a Munich-based digital mental health platform offering structured psychological programs and therapist-led services in Germany. It is a direct competitor to Sympatient in the German regulated mental health market, serving similar patient populations (anxiety, depression) with hybrid digital/clinician care models.
- HelloBetter: HelloBetter is a German digital therapeutics company offering prescription-grade DTx products (e.g., for depression, insomnia, anxiety) reimbursed under §33a SGB V. It is a direct peer to Sympatient's Invirto DTx business and competes for the same payer contracts and clinical evidence-based positioning.
- Selfapy: Selfapy is a Berlin-based digital therapeutics company offering online psychological courses and DTx products reimbursed by German health insurers. It competes directly with Sympatient in the digital mental health category, with similar business model and regulatory positioning.
- GAIA AG: GAIA AG is a Hamburg-based pioneer in digital therapeutics (DTx) with evidence-based products for depression, anxiety, and other conditions reimbursed in Germany and other markets. It is one of the closest direct peers to Sympatient's DTx strategy and shares similar regulatory and reimbursement mechanics.
Emerging players
- Meru Health: Meru Health is a Nordic-origin digital mental health platform offering therapist-supported digital programs for anxiety, depression, and burnout. It overlaps with Sympatient in digital mental health infrastructure and care delivery, though it operates primarily in the US and Nordic markets rather than Germany.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
Sympatient social profiles
Digital presenceSympatient compliance and trust
Trust signalCompliance2 records
Sympatient financial estimates
Financial estimateRevenue estimate
Valuation estimate
Sympatient leadership team
Management profileNumber of profiles
Profiles4 records
Sympatient funding detail
Funding detailFunding overview
Funding rounds2 records
Investors3 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Sympatient M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Sympatient
What does Sympatient do?
Sympatient develops PsyOS®, an operating system for modern psychotherapy that connects software, services, and data within Germany's regulated healthcare system. The platform integrates patient access, practice operations, treatment workflows, AI-supported documentation, and digital therapeutics. Through its network of licensed clinicians, the company delivers psychotherapy care via the Digital Anxiety Clinic, offering digital, classical, and hybrid therapy options reimbursed through statutory and private health insurance frameworks including §140a SGB V selective contracts.
Is Sympatient a public or private company?
Sympatient is a private company. It is classified as venture growth investor backed and is currently operating.
When was Sympatient founded?
Sympatient was founded in 2018. It employs 51 to 100 people.
Where is Sympatient based?
Sympatient is headquartered in Hamburg, Germany, in the Europe region.
How does Sympatient make money?
Four revenue lines are on record. Statutory Health Insurance Reimbursement is the primary driver. The others are selective Contracts (§140a SGB V), private Health Insurance Reimbursement and digital Anxiety Clinic Services.
Who are Sympatient's main competitors?
Broad incumbents on record are Kry/Livi, Doctolib and Zava. Direct peers are Minddoc, HelloBetter, Selfapy and GAIA AG. Meru Health is listed as an emerging player.
Does Sympatient have an API?
No public API is recorded for Sympatient.
What industry is Sympatient in?
Sympatient's product category is Digital Mental Health Services. Its primary akta.pro industry code is HLALAEAH, Serious Mental Illness (SMI) Telepsychiatry & Care Coordination Platforms, with a secondary code of HLACANAO, DTx/SaMD Deployment, Integration & Reimbursement Enablement. Its NAICS code is 624 and its SIC code is 8000.